subscribeSubscribe
Alvotech`s AVT05 Simponi® Biosimilar Topline Results

Alvotech`s AVT05 Simponi® Biosimilar Topline Results
GLOBENEWSWIRE
24 Apr 2024
Share Share
Centocor`s Biologic Simponi (golimumab) Receives Approval in the U.S.

Centocor`s Biologic Simponi (golimumab) Receives Approval in the U.S.
FDA
16 Nov 2023
Share Share
Centocor`s Biologic Simponi (Golimumab) Receives Approval in the U.S.

Centocor`s Biologic Simponi (Golimumab) Receives Approval in the U.S.
FDA
30 Mar 2023
Share Share
J&J Ulcerative Colitis Clinical Trial Produces High Rate of Remission

J&J Ulcerative Colitis Clinical Trial Produces High Rate of Remission
Hayden Schmidt PHARMANEWSINTEL
13 Oct 2022
Share Share
Study of Guselkumab & Golimumab Therapy Show Higher Rates of Clinical Remission

Study of Guselkumab & Golimumab Therapy Show Higher Rates of Clinical Remission
PRNEWSWIRE
10 Oct 2022
Share Share
Lupin, DKSH enter pact to commercials Alvotech biosimilars in Philippines

Lupin, DKSH enter pact to commercials Alvotech biosimilars in Philippines
ECONOMIC TIMES
07 Sep 2022
Share Share
Lupin and DKSH sign exclusive licensing and supply agreement to market five

Lupin and DKSH sign exclusive licensing and supply agreement to market five
EXPRESS PHARMA
06 Sep 2022
Share Share
Results of Novel Study Show Adults with UC Achieved Higher Response Rates

Results of Novel Study Show Adults with UC Achieved Higher Response Rates
PRNEWSWIRE
19 Feb 2022
Share Share
Bio-Thera Solutions Initiates Phase III Clinical Trial for BAT2506

Bio-Thera Solutions Initiates Phase III Clinical Trial for BAT2506
BUSINESSWIRE
08 Jun 2021
Share Share
Bio-Thera Solutions Initiates Phase III Clinical Trial for BAT2506

Bio-Thera Solutions Initiates Phase III Clinical Trial for BAT2506
BUSINESSWIRE
08 Jun 2021
Share Share